Enveric Biosciences, Inc. (ENVB) Form 10-Q Quarterly Reports
Enveric Biosciences, Inc. (ENVB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ENVB
CIK: 890821
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerThomas Cantwell
Audit LocationMorristown, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001493152-26-038418 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001493152-26-038385 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000929638-26-003073 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001172661-26-003572 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001493152-26-037652 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-09 | 8-K | 0001493152-26-027976 | View SEC Doc Filr Page |
| 424B5 | 2026-06-09 | — | 424B5 | 0001493152-26-027975 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-08 | 8-K | 0001493152-26-027781 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001967056-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001883914-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001597334-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001239463-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001645282-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001761753-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0002025032-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001883966-26-000003 | View SEC Doc Filr Page |
| S-8 | 2026-06-01 | — | S-8 | 0001493152-26-026476 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-22 | 8-K | 0001493152-26-026364 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000929638-26-001905 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001493152-26-023353 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001493152-26-023345 | View SEC Doc Filr Page |
| D | 2026-05-04 | — | D Filing | 0000890821-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-30 | 8-K | 0001493152-26-020410 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001493152-26-020405 | View SEC Doc Filr Page |
| EFFECT | 2026-04-29 | — | EFFECT Filing | 9999999995-26-001390 | View SEC Doc Filr Page |